MCHP
51
6
R
70
7
FDX
40
3
BWA
34
5
MA
65
-2
WU
20
8
ABT
69
-5
ECL
72
2
VRTX
43
-2
K
65
2
DD
56
-4
CMS
61
-6
CI
59
-6
EBAY
56
3
EXR
48
-2
IR
40
-7
RF
60
3
CINF
45
2
GRMN
50
2
DVA
59
-13
MCHP
51
6
R
70
7
FDX
40
3
BWA
34
5
MA
65
-2
WU
20
8
ABT
69
-5
ECL
72
2
VRTX
43
-2
K
65
2
DD
56
-4
CMS
61
-6
CI
59
-6
EBAY
56
3
EXR
48
-2
IR
40
-7
RF
60
3
CINF
45
2
GRMN
50
2
DVA
59
-13
Financhill
Back

Julius Baer Gruppe AG Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
32

JBAXY
Julius Baer Gruppe AG

Last Price:
$13.16
Seasonality Move:
-1.14%
Sell
41

SRPT
Sarepta Therapeutics

Last Price:
$107.93
Seasonality Move:
1.75%
Sell
32
Julius Baer Gruppe AG (JBAXY) is a Sell

Is Julius Baer Gruppe AG a Buy, Sell or Hold?

  • The current Julius Baer Gruppe AG [JBAXY] share price is $13.16. The Score for JBAXY is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • JBAXY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

JBAXY Stock Price Chart

What is Julius Baer Gruppe AG's stock price today?

  • The Julius Baer Gruppe AG share price today is $13.16
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JBAXY is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $107.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

JBAXY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 52.59 Buy
Chaikin Money Flow: 79756 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.54 - 13.74) Buy
Bollinger Bands (100): (12.14 - 13.28) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.94 Sell
Relative Strength Index (14 RSI): 33.84 Sell
Chaikin Money Flow: -502758 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.52 - 119.16) Sell
Bollinger Bands (100): (114.38 - 127.78) Sell

JBAXY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.73 Buy
20-day SMA: 13.21 Sell
50-day SMA: 13.09 Buy
200-day SMA: 12.07 Buy
8-day EMA: 12.88 Buy
20-day EMA: 13 Buy
50-day EMA: 12.97 Buy
200-day EMA: 12.31 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.57 Sell
20-day SMA: 114.25 Sell
50-day SMA: 119.8 Sell
200-day SMA: 128.55 Sell
8-day EMA: 110.88 Sell
20-day EMA: 113.91 Sell
50-day EMA: 117.81 Sell
200-day EMA: 123.39 Sell

Julius Baer Gruppe AG Earnings Growth & JBAXY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.

Julius Baer Gruppe AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):